Sarel Fleishman

Prof. Sarel Fleishman

Weizmann Institute of Science, Reẖovot, Central, Israel
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011
Verified
Book Chapter
Closed access
ALAndrew Leaver-Fay
Andrew Leaver-Fay
MTMichael Tyka
Michael Tyka
SLSteven M. Lewis
Steven M. Lewis
OLOliver F. Lange
Oliver F. Lange
JTJames Thompson
James Thompson
PBPhilip Bradley
Philip Bradley

24 June 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SFSarel Fleishman
Sarel Fleishman
ALAndrew Leaver-Fay
Andrew Leaver-Fay
JCJacob E. Corn
Jacob E. Corn
ESEva-Maria Strauch
Eva-Maria Strauch
SKSagar D. Khare
Sagar D. Khare
DBDavid Baker
David Baker
Macromolecular modeling and design are increasingly useful in basic research, biotechnology, and teaching. However, the absence of a user-friendly modeling framework that provides access to a wide range of modeling capabilities is hampering the wider adoption of computational methods by non-experts. RosettaScripts is an XML-like language for specifying modeling tasks in the Rosetta framework. RosettaScripts provides access to protocol-level functionalities, such as rigid-body docking and sequence redesign, and allows fast testing and deployment of complex protocols without need for modifying or recompiling the underlying C++ code. We illustrate these capabilities with RosettaScripts protocols for the stabilization of proteins, the generation of computationally constrained libraries for experimental selection of higher-affinity binding proteins, loop remodeling, small-molecule ligand docking, design of ligand-binding proteins, and specificity redesign in DNA-binding proteins.

15 August 2010 in Nature Methods
Verified
Journal Article
Open access
PDF file
DFDouglas M Fowler
Douglas M Fowler
CACarlos L Araya
Carlos L Araya
SFSarel Fleishman
Sarel Fleishman
EKElizabeth H Kellogg
Elizabeth H Kellogg
JSJason J Stephany
Jason J Stephany
SFStanley Fields
Stanley Fields
The combination of protein display, moderate selection for protein activity and high-throughput DNA sequencing can be applied to hundreds of thousands of protein variants in parallel, enabling the derivation of sequence-function relationships. We present a large-scale approach to investigate the functional consequences of sequence variation in a protein. The approach entails the display of hundreds of thousands of protein variants, moderate selection for activity and high-throughput DNA sequencing to quantify the performance of each variant. Using this strategy, we tracked the performance of >600,000 variants of a human WW domain after three and six rounds of selection by phage display for binding to its peptide ligand. Binding properties of these variants defined a high-resolution map of mutational preference across the WW domain; each position had unique features that could not be captured by a few representative mutations. Our approach could be applied to many in vitro or in vivo protein assays, providing a general means for understanding how protein function relates to sequence.

13 May 2011 in Science
Verified
Journal Article
Closed access
PDF file
SFSarel Fleishman
Sarel Fleishman
TWTimothy A. Whitehead
Timothy A. Whitehead
DEDamian C. Ekiert
Damian C. Ekiert
CDCyrille Dreyfus
Cyrille Dreyfus
JCJacob E. Corn
Jacob E. Corn
DBDavid Baker
David Baker
Proteins can be designed that bind to specific patches on target proteins to alter their subsequent interactions.

1 July 2016 in Molecular Cell
Verified
Journal Article
Open access
AGAdi Goldenzweig
Adi Goldenzweig
MGMoshe Goldsmith
Moshe Goldsmith
SHShannon E. Hill
Shannon E. Hill
OGOr Gertman
Or Gertman
PLPaola Laurino
Paola Laurino
SFSarel Fleishman
Sarel Fleishman
Upon heterologous overexpression, many proteins misfold or aggregate, thus resulting in low functional yields. Human acetylcholinesterase (hAChE), an enzyme mediating synaptic transmission, is a typical case of a human protein that necessitates mammalian systems to obtain functional expression. We developed a computational strategy and designed an AChE variant bearing 51 mutations that improved core packing, surface polarity, and backbone rigidity. This variant expressed at ∼2,000-fold higher levels in E. coli compared to wild-type hAChE and exhibited 20°C higher thermostability with no change in enzymatic properties or in the active-site configuration as determined by crystallography. To demonstrate broad utility, we similarly designed four other human and bacterial proteins. Testing at most three designs per protein, we obtained enhanced stability and/or higher yields of soluble and active protein in E. coli. Our algorithm requires only a 3D structure and several dozen sequences of naturally occurring homologs, and is available at http://pross.weizmann.ac.il.

27 May 2012 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TWTimothy A Whitehead
Timothy A Whitehead
ACAaron Chevalier
Aaron Chevalier
YSYifan Song
Yifan Song
CDCyrille Dreyfus
Cyrille Dreyfus
SFSarel Fleishman
Sarel Fleishman
DBDavid Baker
David Baker